Production (Stage)
VYNE Therapeutics Inc.
VYNE
$1.04
$0.044.00%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 50.27M | 61.52M | 70.19M | 78.10M | 85.95M |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 4.64M | 2.92M | 3.30M | 5.63M | 4.22M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | 47.00K | 46.00K | 54.00K |
| Total Current Assets | 54.91M | 64.44M | 73.54M | 83.78M | 90.22M |
|
|
|||||
| Total Current Assets | 54.91M | 64.44M | 73.54M | 83.78M | 90.22M |
| Net Property, Plant & Equipment | 169.00K | 206.00K | 122.00K | 151.00K | 180.00K |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 1.34M | 2.26M | 2.54M | 2.72M | 1.27M |
| Total Assets | 56.42M | 66.91M | 76.20M | 86.65M | 91.68M |
|
|
|||||
| Total Accounts Payable | 3.53M | 2.71M | 3.99M | 4.52M | 2.80M |
| Total Accrued Expenses | 5.28M | 8.59M | 7.24M | 3.71M | 1.62M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 63.00K | 99.00K | 123.00K | 120.00K | 117.00K |
| Total Finance Division Other Current Liabilities | 3.41M | 3.42M | 1.31M | 3.41M | 2.40M |
| Total Other Current Liabilities | 3.41M | 3.42M | 1.31M | 3.41M | 2.40M |
| Total Current Liabilities | 12.29M | 14.82M | 12.66M | 11.75M | 6.93M |
|
|
|||||
| Total Current Liabilities | 12.29M | 14.82M | 12.66M | 11.75M | 6.93M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | 25.00K | 63.00K |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | 1.31M |
| Total Liabilities | 12.29M | 14.82M | 12.66M | 11.78M | 8.31M |
|
|
|||||
| Common Stock & APIC | 783.91M | 783.24M | 782.65M | 781.92M | 781.03M |
| Retained Earnings | -739.78M | -731.17M | -719.15M | -706.99M | -697.59M |
| Treasury Stock & Other | -- | 20.00K | 34.00K | -58.00K | -70.00K |
| Total Common Equity | 44.13M | 52.09M | 63.54M | 74.87M | 83.37M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 44.13M | 52.09M | 63.54M | 74.87M | 83.37M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 44.13M | 52.09M | 63.54M | 74.87M | 83.37M |
|
|
|||||